Literature DB >> 21267769

Mast cell: insight into remodeling a tumor microenvironment.

Jing Liu1, Yi Zhang, Jie Zhao, Zhuoshun Yang, Dapeng Li, Foad Katirai, Bo Huang.   

Abstract

Mast cells are of paramount importance to allergies, pathogen immune responses during infections, and angiogenesis, as well as innate and adaptive immune regulations. Beyond all these roles, mast cells are now more and more being recognized as modulators of tumor microenvironment. Notwithstanding mounting evidences of mast cell accumulation in tumors, their exact role in tumor microenvironment is still incompletely understood. In this review, we discuss the significant role of mast cells in the remodeling of tumor microenvironment by either releasing various factors after activation or interacting with other cells within tumor and, as a result, the possible role of mast cell in cancer invasion and metastasis. We also discuss recent findings that mast cells actively release microparticles, which account for the transfer of membrane-type receptor signal and regulatory molecules such as microRNAs to tumor cells and immune cells. These findings on mast cells provide further insights into the complexity of tumor microenvironment remodeling. © Springer Science+Business Media, LLC 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21267769     DOI: 10.1007/s10555-011-9276-1

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  25 in total

1.  Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer.

Authors:  Zheng Liu; Yu Zhu; Le Xu; Junyu Zhang; Huyang Xie; Hangcheng Fu; Quan Zhou; Yuan Chang; Bo Dai; Jiejie Xu
Journal:  Oncoimmunology       Date:  2018-08-01       Impact factor: 8.110

2.  A method to integrate patterned electrospun fibers with microfluidic systems to generate complex microenvironments for cell culture applications.

Authors:  Patric Wallin; Carl Zandén; Björn Carlberg; Nina Hellström Erkenstam; Johan Liu; Julie Gold
Journal:  Biomicrofluidics       Date:  2012-06-19       Impact factor: 2.800

Review 3.  The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells.

Authors:  Bong Ihn Koh; Yibin Kang
Journal:  EMBO Rep       Date:  2012-05       Impact factor: 8.807

4.  A transcriptomic insight into the impacts of mast cells in lung, breast, and colon cancers.

Authors:  Eun-A Ko; Kenton M Sanders; Tong Zhou
Journal:  Oncoimmunology       Date:  2017-08-08       Impact factor: 8.110

5.  mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells.

Authors:  Daniel Smrz; Mi-Sun Kim; Shuling Zhang; Beverly A Mock; Sárka Smrzová; Wendy DuBois; Olga Simakova; Irina Maric; Todd M Wilson; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  Blood       Date:  2011-11-03       Impact factor: 22.113

Review 6.  Carcinogenesis: the cancer cell-mast cell connection.

Authors:  Maria-Angeles Aller; Ana Arias; Jose-Ignacio Arias; Jaime Arias
Journal:  Inflamm Res       Date:  2018-11-20       Impact factor: 4.575

7.  ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells.

Authors:  Mahandranauth A Chetram; Ayesha S Don-Salu-Hewage; Cimona V Hinton
Journal:  Biochem Biophys Res Commun       Date:  2011-05-24       Impact factor: 3.575

8.  Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment.

Authors:  Luca Danelli; Barbara Frossi; Carlo E Pucillo
Journal:  Oncoimmunology       Date:  2015-03-24       Impact factor: 8.110

9.  Anti-Müllerian hormone inhibits proliferation and induces apoptosis in epithelial ovarian cancer cells by regulating the cell cycle and decreasing the secretion of stem cell factor.

Authors:  Tiansong Zhang; Linhao Deng; Qian Xiong; Shujun Su; Jian Gu
Journal:  Oncol Lett       Date:  2018-06-18       Impact factor: 2.967

10.  ROS-mediated regulation of CXCR4 in cancer.

Authors:  Mahandranauth A Chetram; Cimona V Hinton
Journal:  Front Biol (Beijing)       Date:  2013-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.